Healthcare - Biotechnology - NASDAQ - US
$ 0.2283
-3.14 %
$ 10.9 M
Market Cap
-0.17
P/E
INCOME STATEMENT
0
REVENUE
-50.7 M
OPERATING INCOME
-51.6 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Mustang Bio, Inc.
| Revenue | 0 |
| Cost Of Revenue | 2.22 M |
| Gross Profit | -2.22 M |
| Operating Expenses | 48.5 M |
| Operating Income | -50.7 M |
| Other Expenses | 876 K |
| Net Income | -51.6 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 2.2 | 3.0 | 2.3 | 1.8 | 1.4 | 0.6 | 2 K | 0 | 0 |
| Gross Profit | (2.2) | (3.0) | (2.3) | (1.8) | (1.4) | (0.6) | 2 K | 0 | 0 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 48.5 | 74.9 | 66.7 | 56.8 | 45.9 | 31.2 | 31.8 | 11.4 | 4.3 |
| Selling, General and Administrative Expenses | 9.3 | 12.2 | 11.0 | 9.5 | 9.6 | 6.8 | 11.4 | 2.8 | 0.3 |
| Research and Development Expenses | 39.2 | 63.9 | 55.7 | 47.3 | 36.3 | 24.5 | 20.4 | 8.5 | 4.0 |
| Operating Income | (50.7) | (76.2) | (66.7) | (56.8) | (45.9) | (31.2) | (31.8) | 11.4 | (4.3) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 1.3 | 3.4 | 15 K | 3.9 | 1.8 | 8 K | 8 K | 1.1 | 0.2 |
| Total Other Income | (0.9) | (1.4) | 0.4 | (3.2) | (0.5) | 0.6 | 0.5 | (24.0) | (0.2) |
| Pre-Tax Income | (51.6) | (77.5) | (66.4) | (60.0) | (46.4) | (30.7) | (31.3) | (12.7) | (4.5) |
| NET INCOME | |||||||||
| Tax Provision | 0 | 1.4 | (2.3) | 2.1 | 1.8 | 0.6 | 0.5 | 23.9 | 0 |
| Net Income | (51.6) | (78.9) | (64.1) | (62.1) | (48.2) | (30.7) | (31.3) | (12.7) | (4.5) |
| EPS | 6 | 11.4 | 10.9 | 17.7 | 20 | 17.1 | 18.6 | 7.24 | 6.7 |